Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.71% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Deckers Outdoor
DECK
$12.4B
| $22.1M | 0.02% |
1,655,400
+1,274,400
| +334% | +$15.3M |
|
|
MNTA
877
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $22.1M | 0.02% |
1,583,000
+134,500
| +9% | +$1.82M |
|
|
LKFT
878
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $22.1M | 0.02% |
235,200
-31,300
| -12% | -$2.96M |
|
879
American Airlines Group
AAL
$9.88B
| $22M | 0.02% |
+423,632
| New | +$21.1M |
|
880
First American
FAF
$7.38B
| $22M | 0.02% |
393,000
-176,000
| -31% | -$9.47M |
|
881
Liberty Global Class C
LBTYK
$3.46B
| $22M | 0.02% |
+649,515
| New | +$20M |
|
|
ASRT
882
DELISTED
Assertio
ASRT
| $21.9M | 0.02% |
45,390
+28,403
| +167% | +$11M |
|
883
PBF Energy
PBF
$8.34B
| $21.9M | 0.02% |
+617,700
| New | +$19.1M |
|
884
Commercial Vehicle Group
CVGI
$128M
| $21.8M | 0.02% |
2,040,873
+218,773
| +12% | +$2.1M |
|
885
Middlesex Water
MSEX
$1.1B
| $21.8M | 0.02% |
546,500
+7,700
| +1% | +$332K |
|
886
Vanda Pharmaceuticals
VNDA
$314M
| $21.8M | 0.02% |
1,434,850
+216,600
| +18% | +$3.21M |
|
|
CLDT
887
Chatham Lodging
CLDT
$590M
| $21.8M | 0.02% |
957,800
+418,400
| +78% | +$9.37M |
|
888
Gilat Satellite Networks
GILT
$895M
| $21.8M | 0.02% |
2,814,930
+54,176
| +2% | +$389K |
|
889
Jacobs Solutions
J
$17B
| $21.8M | 0.02% |
399,081
+228,616
| +134% | +$11.7M |
|
890
HSBC
HSBC
$358B
| $21.8M | 0.02% |
461,188
+339,778
| +280% | +$15.4M |
|
|
DCH
891
Dauch Corp
DCH
$1.61B
| $21.7M | 0.02% |
1,275,899
+735,700
| +136% | +$13M |
|
892
Vera Bradley
VRA
$96.7M
| $21.7M | 0.02% |
1,782,500
+29,000
| +2% | +$262K |
|
|
FNSR
893
DELISTED
Finisar Corp
FNSR
| $21.7M | 0.02% |
1,065,600
-2,074,900
| -66% | -$43.2M |
|
894
Builders FirstSource
BLDR
$7.79B
| $21.6M | 0.02% |
992,400
-122,800
| -11% | -$2.33M |
|
895
A10 Networks
ATEN
$2B
| $21.6M | 0.02% |
2,796,200
+503,500
| +22% | +$3.84M |
|
896
Innoviva
INVA
$1.5B
| $21.6M | 0.02% |
1,518,900
+458,520
| +43% | +$6.12M |
|
897
Tenaris
TS
$26.8B
| $21.5M | 0.02% |
674,200
+171,800
| +34% | +$4.97M |
|
898
Preferred Bank
PFBC
$1.26B
| $21.4M | 0.02% |
364,436
+8,381
| +2% | +$509K |
|
|
ALXN
899
DELISTED
Alexion Pharmaceuticals
ALXN
| $21.4M | 0.02% |
178,800
-263,400
| -60% | -$32.1M |
|
|
FLIR
900
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $21.3M | 0.02% |
457,760
-827,700
| -64% | -$37.8M |
|
Similar funds
Jim Simons's Q4 2017 Portfolio in Review
As of Q4 2017, Jim Simons held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Jim Simons's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Jim Simons added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Jim Simons's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Jim Simons fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Jim Simons's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Jim Simons opened 521 new positions and closed 386 in Q4 2017.
- Jim Simons's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.